MedPath

The effect of intralipid in recurrent implantation failure

Phase 3
Recruiting
Conditions
Infertile patient with recurrent implantation failure.
Registration Number
IRCT20221016056198N2
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
70
Inclusion Criteria

Patients with history of recurrent implantation failure who aged less than 40 years
Patients with normal hormone profile
Patients with BMI 20-32

Exclusion Criteria

Women with recurrent pregnancy loss
Women with aged more than 40 years
Women with endometriosis
Women with coagulation disorder
Women with allergy to soya and egg
Women with Liver, Heart and Renal disease
Women with high cholestrole

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Implantation rate :The ratio of implanted embryos to transferred embryos. Timepoint: 7 weeks after embryo transfer. Method of measurement: Vaginal Sonography.
Secondary Outcome Measures
NameTimeMethod
Biochemical pregnancy rate. Timepoint: 14 days after embryo transfer. Method of measurement: Blood test.
© Copyright 2025. All Rights Reserved by MedPath